NCT06275308 Effect of Raised End-Tidal pCo2 on Choroidal Volume
| NCT ID | NCT06275308 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Intraocular Pressure |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-02-27 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2023-02-27 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is to investigate the relationship between arterial carbon dioxide (CO2) concentration and vitreous pressure on the choroidal volume by integrated intraoperative OCT imaging under eye exams under anesthesia.
Eligibility Criteria
Inclusion Criteria: * any child undergoing an eye exam under anesthesia for an ophthalmologic reason. * children between the ages newborn to 8 years of age. Exclusion Criteria: * children who are not having an eye exam under anesthesia. * children with a known medical diagnosis that affect the eye to be studied * \* children over the age of 8 years of age. * \* children with altered cerebral autoregulation, increased intracranial pressure, pulmonary hypertension, or any other condition deemed appropriate by the anesthesiologist. * children in whom a laryngeal mask airway will not be used
Contact & Investigator
Amy Monroe, MPH, MBA
STUDY DIRECTOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT06275308 clinical trial?
This trial is open to participants of all sexes, up to 8 Years, studying Intraocular Pressure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06275308 currently recruiting?
Yes, NCT06275308 is actively recruiting participants. Contact the research team at monroeal@upmc.edu for enrollment information.
Where is the NCT06275308 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT06275308 clinical trial?
NCT06275308 is sponsored by University of Pittsburgh. The principal investigator is Amy Monroe, MPH, MBA at University of Pittsburgh. The trial plans to enroll 20 participants.